BASF rolled out Peptovitae, a series of four patented peptides that represent a new generation of scientifically developed biomimetic peptides. 
 
“Increasingly, consumers are looking for safe and effective skin care-regime-based solutions with high efficacy as an alternative to procedure-based treatments to address their personal skin needs,” said Eunice Jeong, head of regional market development, personal care solutions, care chemicals, BASF Asia Pacific. “The strong growth of dermocosmetics in China and the doubling of the share of dermocosmetics in the global beauty market over the last 15 years are evidence of the robust growth in products containing peptides and the shift by consumers towards biomimetic skin care regimes.”
 
Peptovitae was developed in Asia through an exclusive relationship with Caregen, a Korean-based company and global leader in biomimetic peptide research and development. The Peptovitae series addresses a wider range of skin concerns than are traditionally associated with the use of peptides. These new bioactives from BASF’s Care Creations address personal care skin benefits related to combatting the signs of aging (Peptovitae Matrix), enhancing the brightness of skin (Peptovitae Bright), soothing skin prone to dryness and itching (Peptovitae Derma) as well as calming and moisturizing skin (Peptovitae Clear). 
 
The double-layered, liposome-based encapsulation system used in the Peptovitae series allows finished products to deliver the benefit of these biomimetic peptides to skin appearance. 
 
Developed in Asia for global consumer needs, Peptovitae delivers unique biomimetic peptides thanks to the partnership with Caregen, a leader in biomimetic peptides. The resulting products offer potent, proven efficacy to address consumers’ skin needs. 
 
“BASF has adapted these peptides to ensure they meet cosmetic industry standards, thereby making these products available to our customers and consumers,” said Viju Jose, vice president, personal care solutions, care chemicals, BASF Asia Pacific.